Across TCGA pan-cancer cohorts, LINC01870 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01870 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01870 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01870 expression acts as an unfavorable survival marker.

ACC, THCA, and BLCA are the cancer types where LINC01870 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	IV	0.353	0.727	.003	54	view →
THCA	OS	Tertile	IV	0.455	0.871	.002	48	view →
BLCA	DFS	Tertile	III,IV	0.114	0.295	.021	42	view →
CHOL	OS	Tertile	All	0.089	0.727	.001	27	view →
HNSC	DFS	Tertile	All	0.184	0.557	.004	27	view →
UCEC	DFS	Tertile	All	0.793	0.901	.002	24	view →
OV	DFS	Tertile	IV	0.300	0.493	.047	18	view →
TGCT	DFS	Tertile	All	0.321	0.816	<.001	18	view →
BRCA	DFS	Tertile	All	0.908	0.953	.034	18	view →
LUAD	DFS	Tertile	All	0.522	0.674	.023	15	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	9	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

Exploration

Same gene, other analysis: LINC01870 tumor-vs-normal RNA expression · all LINC01870 data types